Stay updated with breaking news from Biox Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Windjammer Capital Investors has announced it has closed its latest fund at $1.3 billion in commitments. The new fund, Windjammer Capital Fund VI, exceeded its $1...
/PRNewswire/ -- Windjammer Capital Investors ("Windjammer"), a national private equity investment firm focused on control equity investments in middle-market...
Lebanon’s Science Olympiad success was a team effortAs the coach of the Lebanon High School Science Olympiad team, I would like to express my thanks and gratitude, on behalf of our students, to the stakeholders in our community who have been so...
Reporting a novel hybrid membrane nanovaccine, composed of mesoporous silica nanoparticle as a delivery carrier
NH Business Review NH companies attract investment and recognition ... and more May 27, 2021 MilliporeSigma’s launches new synthetic cholesterol product, which could be used in mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine. MilliporeSigma has launched a new product nine months ahead of schedule in order to meet what it says is the high demand for lipids, a key component of mRNA-based vaccines and therapeutics. The German manufacturer, which has a location in Jaffrey, NH, is manufacturing the synthetic cholesterol product in Darmstadt, Germany, though it also manufactures lip...